Active substance
Results for the substance dolutegravir+rilpivirine
1 result
About this active substance
The combination of dolutegravir and rilpivirine is used for the treatment of HIV infection in adults with a controlled viral load as part of a maintenance regimen. It works by inhibiting the integration of viral DNA and blocking reverse transcriptase activity.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's weight and renal function. Common side effects include nausea, insomnia, headaches, and dizziness.
This combination is contraindicated in patients with hypersensitivity to any of the components or severe hepatic impairment. Its use also requires regular monitoring of liver and renal function.
This medication is an effective option for patients with HIV who wish to transition to a simplified maintenance regimen, helping to maintain viral control.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's weight and renal function. Common side effects include nausea, insomnia, headaches, and dizziness.
This combination is contraindicated in patients with hypersensitivity to any of the components or severe hepatic impairment. Its use also requires regular monitoring of liver and renal function.
This medication is an effective option for patients with HIV who wish to transition to a simplified maintenance regimen, helping to maintain viral control.